The ATM is proud to reflect on the successful completion of our Regulatory Science and Health Economics course through a dynamic two-day workshop.
Day 1 of the workshop explored deliberative decision-making and delved into the mechanics of incorporating patient preferences into healthcare outcomes. Attendees were introduced to the theoretical underpinnings and practical approaches to patient-centered decision-making, laying a solid foundation for the following day.
Day 2 of the workshop built upon this foundation by articulating the emerging role of patient preferences in regulatory decision-making. It focused on understanding the deliberative processes behind reimbursement recommendations and the methods used to value new health products. The day provided the foundations for developing robust evidence packages aligned with regulatory and reimbursement decisions frameworks. Instructors focused on analytical approaches to evaluating risk-benefit trade-offs, live coding, cost-effectiveness analysis and clinical trial design considerations.
Presenters (left to right) Dr. Dean Regier, Dr. Sam Pollard, Deirdre Weymann, Emanuel Krebs
The success of this workshop builds on our world-leading research and training in regulatory science, led by ATM faculty and associates Dr. Dean Regier, Dr. Sam Pollard, Deirdre Weymann, and Emanuel Krebs. We would also like to thank the 17 learners who actively engaged in the discussions.
About this Course
Regulatory Science and Health Economics is the second of two courses in the ATM’s UBC Micro-certificate in Regulatory Affairs in the Life Sciences. The first course is Introduction to Regulatory Affairs. For more information, visit the ATM Education page.